F901318 Multiple Ascending Dose Study

NCT02342574 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Invasive Aspergillosis

Interventions

DRUG: F901318
DRUG: Placebo

Sponsor

F2G Ltd

Collaborators

[object Object]